Company news
Aytu BioPharma, Inc. news in 2023
Aytu BioPharma, Inc.'s news releases, calls and decks from 2023, newest first.
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
November 13, 2023
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
November 6, 2023
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
October 25, 2023
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
September 20, 2023
Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority
July 30, 2023
Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
July 9, 2023
Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market
June 12, 2023
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
June 8, 2023
Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results
May 10, 2023
Aytu BioPharma Subleases a Portion of Its Manufacturing Facility
April 30, 2023
Aytu BioPharma Announces Approval of Adzenys XR-ODT(R)Manufacturing Site Transfer
April 26, 2023
Aytu BioPharma Reports Second Quarter of Fiscal Year 2023
February 20, 2023
Aytu BioPharma Announces Delayed Filing of Second Quarter Fiscal 2023 Financial Results
February 13, 2023
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 14, 2023
February 6, 2023
Aytu BioPharma Regains Nasdaq Minimum Bid Price Compliance
January 24, 2023
Aytu BioPharma, Inc Continues Availability of Adzenys XR-ODT(R) as the Only FDA-Approved Orally Disintegrating Tablet (ODT) Medication that is Bioequivalent to Adderall XR(R) for ADHD Patients
January 9, 2023
Aytu BioPharma Announces 1-for-20 Reverse Stock Split
January 4, 2023
Calls in 2023
Decks in 2023
- IPO Roadshow (June 2023)
IPO roadshow · 27 slides · Jun 6, 2023